By boosting metabolism and targeting fat breakdown in the liver, these injections can support the bodys natural fat-burning processes
Currently, a major gap in the field that applies here relates to the need for a diagnostic biomarker in humans that correlates with pre-neoplastic disease progression (e.g., indicating a high grade PanIN)
Injectable GLP-1 drugs such as Ozempic, Wegovy, and Mounjaro continue to outperform their pill-based counterparts in nearly every measurable way
rather, it exemplifies how endogenous peptide systems with pleiotropic signaling can be rendered clinically tractable through advances in peptide stabilization, pharmacokinetics, receptor bias, and dosing strategies
For the rest, the choice is primarily about routine and practicality, because the effect feels even